Gastrointestinal Cancer Update

This series bridges the gap between research and patient care by providing medical oncologists and h

Episodes

Total: 322

Dr Christopher Lieu shares his perspectives on the evolving therapeutic landscape for patients with

Dr Daneng Li shares his perspectives on the evolving therapeutic landscape for patients with hepatob

Dr Tanios Bekaii-Saab from Mayo Clinic in Phoenix, Arizona, and Dr Philip A Philip from the Henry Fo

Dr Thierry Alcindor from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Mrinal Gounde

Dr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memori

Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, an

Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler

Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recen

Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Stric

Prof Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates o

Dr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discusses the rol

Professor Thierry André from the Hôpital Saint-Antoine in Paris, France, and Dr Arvind Dasari from M

Dr Robin K (Katie) Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Franc

Dr Yelena Y Janjigian from Memorial Sloan Kettering Cancer Center in New York and Dr Zev Wainberg fr

Dr Ahmed Omar Kaseb from the University of Texas MD Anderson Cancer Center in Houston, Texas, and Pr

Dr Lipika Goyal from The Stanford Cancer Center and Dr Milind Javle from The University of Texas MD

Dr Samuel J Klempner from Massachusetts General Hospital in Boston discusses optimizing the manageme

Prof Eric Van Cutsem from the University Hospitals Leuven in Leuven, Belgium, discusses optimizing t

Featuring a discussion on current and emerging strategies for the treatment of upper GI cancers with

Dr Michael Pishvaian from the Johns Hopkins University School of Medicine in Washington, DC, discuss